2009
DOI: 10.1016/j.exphem.2008.10.002
|View full text |Cite
|
Sign up to set email alerts
|

miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
64
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 115 publications
(70 citation statements)
references
References 47 publications
6
64
0
Order By: Relevance
“…With the help of bioinformatics-based databases (25-28) and published reports (12,13), the search was narrowed down to miR320a as a possible modulator of AQP1 and AQP4. Recent studies have established miR-320a as an inhibitor of the cell cycle gene (POLR3D) and the transferrin receptor gene (TFRC) (4,29). Our AQP1 and AQP4 gene expression profiles were similar FIGURE 2.…”
Section: Discussionsupporting
confidence: 50%
“…With the help of bioinformatics-based databases (25-28) and published reports (12,13), the search was narrowed down to miR320a as a possible modulator of AQP1 and AQP4. Recent studies have established miR-320a as an inhibitor of the cell cycle gene (POLR3D) and the transferrin receptor gene (TFRC) (4,29). Our AQP1 and AQP4 gene expression profiles were similar FIGURE 2.…”
Section: Discussionsupporting
confidence: 50%
“…miR-320 expression levels were found to be downregulated in primary breast cancer (BC) (20) and intrahepatic cholangiocarcinoma (21). miR-320 expression also inhibited HL-60 cell proliferation by targeting transferrin receptor 1 (CD71) (22).…”
Section: Introductionmentioning
confidence: 99%
“…As no increase in cell death was observed with miR-320 overexpression, the lower cell number was likely due to decreased cell division, an effect of PP2A activity. Thus far 3 targets have been verified for miR-320: the PTEN component ETS2 [17], histone deacetylase 4 [18], and the transferrin receptor CD71 [19]. None of these targets have been implicated in neurite outgrowth, but ETS2 is required for breast cell proliferation [20] and CD71 enhances proliferation in B-cell lymphoma cells [21].…”
Section: Discussionmentioning
confidence: 99%